Clinical trials
Carotid Artery Diseases trials in Italy
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
16 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2010 | 1 |
| 2013 | 2 |
| 2018 | 2 |
| 2019 | 3 |
| 2020 | 2 |
| 2021 | 2 |
| 2022 | 1 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 6 |
| Recruiting | 4 |
| Unknown status | 4 |
| Active, not recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 4 |
| Azienda Ospedaliera Ordine Mauriziano di Torino | 1 |
| Azienda Ospedaliera di Perugia | 1 |
| Azienda Ospedaliero, Universitaria Pisana | 1 |
| Azienda Ospedaliero-Universitaria di Modena | 1 |
| Contego Medical, Inc. | 1 |
| Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico | 1 |
| Gardia Medical | 1 |
| Invatec S.p.A. | 1 |
| Neuromed IRCCS | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carotid Artery Diseases | 16 |
| Carotid Stenosis | 7 |
| Stroke | 5 |
| Coronary Artery Disease | 1 |
| Heart Diseases | 1 |
| Heart Valve Diseases | 1 |
| Hypothermia | 1 |
| Plaque, Amyloid | 1 |
| Plaque, Atherosclerotic | 1 |
Trials
Showing 26 to 16 of 16. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.